Concepedia
Statistics
Publications
4
Citations
88
H-Index
Active since
2019
Affiliations
James A. Haley Veterans' Hospital(Current)
University of South Florida
TransGenex Nanobiotech (United States)
Roukiah Khalil is an author at James A. Haley Veterans' Hospital specializing in pharmacology, medicine, and oncology.
Publications per year
2019–2023
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway
Ryan Green, Mark Howell, Roukiah Khalil et al. · Scientific Reports · 2019 · 34 citations · Full text
Medicine, Oncology, Pharmacology +17
Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis
Mark Howell, Ryan Green, Roukiah Khalil et al. · FASEB BioAdvances · 2019 · 25 citations · Full text
Medicine, Oncology, Pharmacology +16
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
Rinku Dutta, Roukiah Khalil, Karthick Mayilsamy et al. · Frontiers in Immunology · 2021 · 19 citations · Full text
Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
Roukiah Khalil, Ryan J. Green, Kavya Sivakumar et al. · Cancers · 2023 · 10 citations · Full text
1–4 of 4